SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : MDA - Market Direction Analysis
SPY 683.38+0.1%Nov 12 4:00 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: pater tenebrarum who wrote (39200)2/4/2000 10:19:00 PM
From: Casaubon  Read Replies (2) of 99985
 
Heinz,

I do not subscribe to the new era theory but, increased productivity has influenced many old era endeavors. There is no doubt that the drug development time cycle has been reduced. Not only has this reduced the time from the lab to the clinic, but the specificity of the new drugs allow for easier read-outs (clinical endpoints) in trials. Thus the amount of time (and BIG MONEY), and the number of actual clinical trials, necessary to determine the fate of a new therapeutic agents has been radically reduced.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News